CERS — CERUS CORP

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1020214 ·
Last close
$1.90
Market Cap
$383.71M
52W High
$3.47
52W Low
$1.47
ADV30
2,293,004
Next earnings
2026-11-02

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 57,714,000 30,265,000 383,000 -550,000 204,729,000 16,350,000 128,367,000
Jun 2026 57,441,000 29,532,000 -1,858,000 -2,940,000 205,187,000 17,980,000 134,472,000
Mar 2026 53,661,000 27,894,000 -354,000 -1,640,000 222,908,000 27,850,000 154,622,000
Dec 2025 57,751,000 29,749,000 -641,000 -2,184,000 221,859,000 19,961,000 156,894,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$3,497,000
Investing CF
$17,940,000
Financing CF
$-21,105,000
CapEx
$-3,003,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.03
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,086,285,000
Inventory
$64,689,000
Receivables
$30,560,000
ST Investments
$40,759,000
EBIT TTM
$-236,000
Pretax Income TTM
$-7,023,000
Interest Exp TTM
$6,787,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$226,567,008
EBITDA
$-748,000
Free Cash Flow
$2,131,375
Enterprise Value
$426,459,456
Total Cash
$57,109,000
Total Debt
$74,960,000
Shares Out
201,954,184
Trailing EPS
$-0.04
Book Value
$0.38
ROE
-10.7%
ROA
-0.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 206,133,000 -8,681,000 -15,627,000 221,859,000 156,894,000 64,224,000 4,837,000
Dec 2024 180,270,000 -14,225,000 -20,918,000 200,917,000 144,021,000 56,145,000 11,359,000
Dec 2023 156,367,000 -26,325,000 -37,489,000 197,748,000 144,304,000 52,650,000 -43,168,000
Dec 2022 162,048,000 -34,081,000 -42,779,000 218,092,000 149,530,000 67,610,000 -25,615,000

TTM Snapshot

Revenues TTM
$277,203,000
NetIncome TTM
$-6,783,000
OpCashFlow TTM
—
Assets (Latest)
$205,187,000
Forward EPS
$-0.01

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $3.00 · spot: $1.94 · call volume: 218 · put volume: 270
Expected Move to 2026-12-18: ±$0.20 (10.31%) — implied range $1.74 – $2.14 · ATM straddle on $2.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
BWAY Brainsway Ltd. $366.29M $9.11 —
CV CapsoVision, Inc $356.50M $6.65 —
MOBI Mobia Medical, Inc. $419.80M $12.61 —
EMBC Embecta Corp. $348.46M $6.15 —
BRSYF Brainsway Ltd. $427.01M $10.62 —

News headlines (Yahoo Finance, 1h cache)

Cerus Corporation to Participate in Upcoming Investor Conferences
2026-11-17 21:01 · Yahoo
Cerus Corporation Q3 2026 Earnings Call Summary
2026-11-03 13:30 · Yahoo
Cerus: 3 Key Takeaways for Long-Term Investors
2026-11-03 11:59 · Yahoo
Cerus (CERS) Q3 2026 Earnings Call Transcript
2026-11-03 10:03 · Yahoo
Cerus Corp (CERS) Q3 2026 Earnings Call Highlights: Revenue Climbs 10% as Adjusted EBITDA ...
2026-11-03 05:06 · Yahoo
Cerus Q3 Earnings Call Highlights
2026-11-03 00:14 · Yahoo
Cerus: Q3 Earnings Snapshot
2026-11-02 23:05 · Yahoo
Cerus Corporation Announces Third Quarter 2026 Financial Results
2026-11-02 21:05 · Yahoo
Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells
2026-11-02 21:00 · Yahoo
Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026
2026-10-19 20:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.